Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis.
[en] Systemic-onset juvenile chronic arthritis (SoJCA) is associated with high levels of circulating interleukin-6 (IL-6) and is frequently complicated by severe microcytic anemia whose pathogenesis is unclear. Therefore, we studied 20 consecutive SoJCA patients with hemoglobin (Hb) levels <12 g/dL, evaluating erythroid progenitor proliferation, endogenous erythropoietin production, body iron status, and iron supply for erythropoiesis. Hb concentrations ranged from 6.5 to 11.9 g/dL. Hb level was directly related to mean corpuscular volume (r = .82, P < .001) and inversely related to circulating transferrin receptor (r = -.81, P < .001) suggesting that the severity of anemia was directly proportional to the degree of iron-deficient erythropoiesis. Serum ferritin ranged from 18 to 1,660 microgram/L and was unrelated to Hb level. Bone marrow iron stores wore markedly reduced in the three children investigated, and they also showed increased serum transferrin receptor and normal-to-high serum ferritin. All 20 patients had elevated IL-6 levels and normal in vitro growth of erythroid progenitors. Endogenous erythropoietin (epo) production was appropriate for the degree of anemia as judged by both the observed to predicted log (serum epo) ratio 10.95 +/- 0.12) and a comparison of the serum epo-Hb regression found in these subjects with that of thalassemia patients. Multiple regression analysis showed that serum transferrin receptor was the parameter most closely related to hemoglobin concentration: variation in circulating transferrin receptor explained 61% of the variation in Hb level (P < .001). In 10 severely anemic patients, amelioration of anemia following intravenous iron administration resulted in normalization of serum transferrin receptor. Defective iron supply to the erythron rather than blunted epo production is the major cause of the microcytic anemia associated with SoJCA. A true body-iron deficiency caused by decreased iron absorption likely complicates long-lasting inflammation in the most anemic children, and this can be recognized by high serum transferrin receptor levels. Although oral iron is of no benefit, intravenous iron saccharate is a safe and effective means for improving iron availability for erythropoiesis and correcting this anemia. Thus, while chronically high endogenous IL-6 levels do not appear to blunt epo production, they are probably responsible for the observed abnormalities in iron metabolism. Anemia of chronic disease encompasses a variety of anemic conditions whose peculiar features may specifically correlate with the type of cytokine(s) predominantly released.
Disciplines :
Hematology
Author, co-author :
Cazzola, M.
Ponchio, L.
de Benedetti, F.
Ravelli, A.
Rosti, V.
Beguin, Yves ; Centre Hospitalier Universitaire de Liège - CHU > Hématologie clinique
Invernizzi, R.
Barosi, G.
Martini, A.
Language :
English
Title :
Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis.
Publication date :
1996
Journal title :
Blood
ISSN :
0006-4971
eISSN :
1528-0020
Publisher :
American Society of Hematology, Washington, United States - District of Columbia
Means RT, Krantz SB: Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 80:1639, 1992
Johnson CS, Keckler DJ, Topper MI, Braunschweiger PG, Furmanski P: In vivo hematopoietic effects of recombinant interleukin-1α in mice: Stimulation of granulocytic, monocylic, megakaryocytic, and early erythroid progenitors, suppression of late-stage erythropoiesis, and reversal of erythroid suppression with erythropoietin. Blood 73:678, 1989
Johnson CS, Cook CA, Furmanski P: In vivo suppression of erythropoiesis by tumor necrosis factor-α (TNF-αa): Reversal with exogenous erythropoietin (EPO). Exp Hematol 18:109, 1990
Means RT, Dessypris EN, Krantz SB: Inhibition of human erythroid colony-forming units by tumor necrosis factor requires accessory cells. J Clin Invest 86:538, 1990
Means RT, Dessypris EN, Krantz SB: Inhibition of human erythroid colony-forming units by interleukin-1 is mediated by gamma interferon. J Cell Physiol 150:59, 1992
Faquin WC, Schneider TJ, Goldberg MA: Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 79:1987, 1992
Baer AN, Dessypris EN, Goldwasser E, Krantz SB: Blunted erythropoietin response to anaemia in rheumatoid arthritis. Br J Haematol 66:479, 1987
Hochberg MC, Arnold CM, Hogan BB, Spivak JL: Serum immunoreactive erythropoietin in rheumatoid arthritis: Impaired response to anemia. Arthritis Rheum 31:1318, 1988
Takashima N, Kondo H, Kashiwazaki S: Suppressed serum erythropoietin response to anemia and the efficacy of recombinant erythropoietin in the anemia of rheumatoid arthritis. J Rheumatol 17:885, 1990
Pincus T, Olsen N, Russel IJ, Wolfe F, Harris ER, Schnitzer TJ, Boccagno JA, Krantz SB: Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. Am J Med 89:161, 1990
Salvarani C, Lasagni D, Casali B, Macchioni P, Boiardi L, Rossi F, Rivasi P, Portioli I: Recombinant human erythropoietin therapy in patients with rheumatoid arthritis with the anemia of chronic disease. J Rheumatol 18:1168, 1991
Bergström J: New aspects of erythropoielin treatment. J Intern Med 233:445, 1993
Cazzola M, Pootrakul P, Bergamaschi G, Huebers HA, Eng M, Finch CA: The adequacy of iron supply for erythropoiesis: In vivo observations in humans. J Lab Clin Med 110:734, 1987
de Benedetti F, Massa M, Robbioni P, Ravelli A, Burgio GR, Martini A: Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis Rheum 34:1158, 1991
de Benedetti F, Robbioni P, Massa M, Viola S, Albani S, Martini A: Serum interleukin-6 levels and joint involvement in poly-articular and pauciarticular juvenile chronic arthritis. Clin Exp Rheum 10:493, 1992
Cazzola M, Beguin Y: New tools for clinical evaluation of erythropoiesis and iron status in man. Br J Haematol 80:278, 1992
Martini A, Ravelli A, Di Fuccia G, Rosti V, Cazzola M, Barosi G: Intravenous iron therapy for severe anaemia in systemic-onset juvenile chronic arthritis. Lancet 344:1052, 1994
Brewer EJ Jr, Bass J, Baum J, Cassidy JT , Fink C, Jacobs J, Hanson V, Levinson JE, Schaller J, Stillman JS: Current proposed revision of JRA criteria. Arthritis Rheum 20:195, 1977 (suppl)
Wood PHN: Special meeting on: Nomenclature and classification of arthritis in children, in Munthe E (ed): The Care of Rheumatic Children. Basel, Switzerland, Eular, 1978, p 47
Invernizzi R, Cazzola M, De Fazio P, Rosti V, Ruggeri G, Arosio P: Immunocytochemical detection of ferritin in human bone marrow and peripheral blood cells using monoclonal antibodies specific for the H and L subunits. Br J Haematol 76:427, 1990
Beguin Y, Clemons GK, Pootrakul P, Fillet G: Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin. Blood 81:1067, 1993
Carlo Stella C, Cazzola M, Ganser A, Bergamaschi G, Pedrazzoli P, Hoelzer D, Ascari E: Synergistic antiproliferative effect of recombinant interferon gamma with recombinant interferon alpha on chronic myelogenous leukemia hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, CFU-GM). Blood 72:1293, 1988
de Benedetti F, Massa M, Pignatti P, Albani S, Novick D, Martini A: Serum soluble interleukin 6 (IL-6) receptor and IL-6/ soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis. J Clin Invest 93:2114, 1994
Hansen TM, Hansen NE: Serum ferritin as indicator of iron responsive anaemia in patients with rheumatoid arthritis. Ann Rheum Dis 45:596, 1986
Balaban EP, Sheehan RG, Demian SE, Cox JV, Frenkel EP: Evaluation of bone marrow iron stores in anemia associated with chronic disease: A comparative study of serum and red cell ferritin. Am J Hematol 42:177, 1993
Montecucco C, Caporali R, Invernizzi R: Iron status in Still's disease. Lancet 345:58, 1995 (letter)
Houssiau FA, Devogelaer JP, van Damme J, Nagant de Deuxchaisnes C, van Snick J: Interleukin 6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritis. Arthritis Rheum 31:784, 1988
Vreungdenhil G, Lowenberg B, van Ejik HG, Swaak AJG: Anaemia of chronic disease in rheumatoid arthritis: raised serum interleukin 6 (IL-6) levels and the effects of IL-6 and anti-IL-6 on in vitro erythropoiesis. Rheumatol Int 10:127, 1990
Bernad A, Kopf M, Kulbacki R, Weich N, Koehler G, Gutierrezramos JC: Interleukin-6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system. Immunity 1:725, 1994
Jacobsen SE, Ruscetti FW, Okkenhaug C, Lien E, Ortiz M, Veiby OP, Keller JR: Distinct and direct synergistic effects of IL-1 and IL-6 on proliferation and differentiation of primitive murine hematopoietic progenitor cells in vitro. Exp Hematol 22:1064, 1994
van Gameren MM, Willemse PHB, Mulder NH, Limburg PC, Groen HJM, Vellenga E, de Vries EGE: Effects of recombinant human interleukin-6 in cancer patients: a phase I-II study. Blood 84:1434, 1994
Nieken J, Mulder NH, Buter J, Vellenga E, Limburg PC, Piers DA, de Vries EGE: Recombinant human interleukin-6 induces a rapid and reversible anemia in cancer patients. Blood 86:900, 1995
Atkins MB, Kappler K, Mier JW, Isaacs RE, Berkman EM: Interleukin-6-associated anemia: Determination of the underlying mechanism. Blood 86:1288, 1995
Ferguson BJ, Skikne BS, Simpson KM, Baynes RD, Cook JD: Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency anemia. J Lab Clin Med 19:385, 1992
Weber J, Werre JM, Julius HW, Marx JJM: Decreased iron absorption in patients with active rheumatoid arthritis, with and without iron deficiency. Ann Rheum Dis 47:404, 1988
Bentley DP, Williams P: Parenteral iron therapy in the anaemia of rheumatoid arthritis. Rheumatol Rehabil 21:88, 1982
Hirayama M, Kohgo Y, Kondo H, Shintani N, Fujikawa K, Sasaki K, Kato J, Niitsu Y: Regulation of iron metabolism in HepG2 cells: A possible role for cytokines in the hepatic deposition of iron. Hepatology 18:874, 1993
Kobune M, Kohgo Y, Katp J, Myazaki E, Niitsu Y: Interleukin-6 enchances hepatic transferrin uptake and ferritin expression in rats. Hematology 19:6, 1994